Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 54:e213-e214, Hackett,M.L.,et al, 2023
Selective Serotonin Reuptake Inhibitors May be Helpful in Most Patients with Stroke
Stroke 43:3150-3151,3154, Chollet, F., 2012
Should Every Patient with Stroke be on Selective Serotonin Reuptake Inhibitors?
Stroke 43:3152-3153,3154, Marshall, R.S., 2012
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 41:e460-e461, Hackett,M.L., et al, 2010
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med 146:34-44, Calabrese,L.H.,et al, 2007
Management of Depression After Stroke
Stroke 36:1092-1097, Hackett,M.L.,et al, 2005
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 35:2610-2611, Horrocks,J.A.,et al, 2004
Effects of Fluoxetine and Maprotiline on Functional Recovery in Poststroke Hemiplegic Pts Undergoing Rehab Therapy
Stroke 27:1211-1214, Dam,M.,et al, 1996
Effective Treatment of Poststroke Depression with the Selective Serotonin Reuptake Inhibitor Citalopram
Stroke 25:1099-1104, Andersen,G.,et al, 1994
Nortriptyline Treatment of Post-Stroke Depression:A Double-Blind Study
Lancet 1:298-300, Lipsey,J.R.,et al, 1984
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
Diffuse Cerebral Vasoconstriction (Call-Fleming Syndrome) and Stroke Associated with Antidepressants
Neurol 67:159-160, Noskin,O.,et al, 2006
Antidepressant Therapy After Stroke, A Double-Blind Trial
Arch Neurol 43:763-765, Reding,M.J.,et al, 1986
Fibromyalgia
BMJ 345:g1224, Rahman, A.,et al, 2014
Inhibition of Serotonin Reuptake by Antidepressants and Cerebral Microbleeds in the General Population
Stroke 45:1951-1957, Aarts, N.,et al, 2014
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
The Serotonin Syndrome
NEMJ 352:1112-20, Boyer, E.W. & Shannon, M., 2005
Attention-Deficit/Hyperactivity Disorder in Adults
JAMA 292:619-623, Wilens,T.E.,et al, 2004
Tinnitus
NEJM 347:904-910, Lockwood,A.H.,et al, 2002
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
A 55-Year-Old Man with Attention-Deficit/Hyperactivity Disorder
JAMA 280:1086-1092, Biederman,J., 1998
Tinnitus:It's Causes, Diagnosis, and Treatment
BMJ 306:1490-1491, Luxon,L.M., 1993
Diabetic Sensory and Motor Neuropathy
NEJM 374:1455-1464, Vinik, A.I.,et al, 2016
Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015
Postherpetic Neuralgia
NEJM 371:1526-1533, Johnson, R.W.,et al, 2014
Treatment of Fibromyalgia Syndrome with Antidepressants: A Meta-Analysis
JAMA 301:198-209, H�user,W.,et al, 2009
Facial Pain
The Neurologist 15:171-177, Graff-Radford,S.B., 2009
Effects of Treatments for Symptoms of Painful Diabetic Neuropathy: Systematic Review
BMJ 335:87-90, Wong,M.-C.,et al, 2007
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
Mirtazapine is Effective in the Prophylactic Treatment of Chronic Tension-Type Headache
Neurol 62:1706-1711, Bendtsen,L. &Jensen,R., 2004
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Opioids Versus Antidepressants in Postherpetic Neuralgia
Neurol 59:1015-1021, Raja,S.N.,et al, 2002
Management of Chronic Tension-Type Headache with Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination
JAMA 285:2208-2215, Holroyd,K.A.,et al, 2001
Evidence Based Management of Attention Deficit Hyperactivity Disorder
BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
Antidepressants and Chronic Pain
BMJ 314:763-764, McQuay,H.J.&Moore,R.A., 1997
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
A Guide to Understanding & Use of Tricyclic Antidepress in Manage of Fibromyalgia & Other Chronic Pain Syndr
Arch Int Med 156:1047-1052, Godfrey,R.G., 1996
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
The Treatment of Postherpetic Neuralgia
Neurol 45 (Suppl 8) :s58-s60995., Watson,C.P.N., 1995
Neuropathic Pain of Peripheral Origin:Advances in Pharmacologic Treatment
Neurol 45 (suppl 8) :s17-s25995., Galer,B.S., 1995
Anticonvulsant Effect of Fluoxetine in Humans
Neurol 45:1926-1927, Favale,E.,et al, 1995
Postherapetic Neuralgia
Semin Neurol 14:247-254, Rowbotham,M.C., 1994
Painful Polyneuropathy:Diagnosis, Pathophysiology, and Management
Semin Neurol 14:237-246, Galer,B.S., 1994
Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994
Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993
Psychotropic Drugs and Sleep
BMJ 306:1331-1334, Eisen,J.,et al, 1993
A Random Trial of Nortriptyline for Severe Chronic Tinnitus, Effects on Depression, Disability, & Tinnitus Sympt
Arch Int Med 153:2251-2259, Sullivan,M.,et al, 1993